logo
logomenu
News and Media
LoginOrder A Test
particle bg
Providers

Cancer testing // Solid Tumor Genetic Testing

Solid Tumor Genetic Testing

Order this test for your patients

Solid Tumor Genetic Testing

Scroll to view

what

What is Solid Tumor Genetic Testing?

why

Why Solid Tumor Genetic Testing?

who

Who needs Solid Tumor Genetic Testing?

technology

What technologies are used in Solid Tumor Genetic Testing?

What is Solid Tumor Genetic Testing?

Solid tumor genetic testing is a diagnostic method that involves analyzing the genetic material in tumors from various organs, such as the lungs, breast, colon, pancreas, prostate, skin, brain, ovary, stomach, liver, bladder, thyroid, and kidney. This approach is crucial for unlocking detailed information about the genetic mutations and variations present within a patient's tumor and offers insights into the tumor's genetic underpinnings.

Identified Genes in our Solid Tumor Genetic Test (52 genes, 23 RNA fusion drivers)

Key features

Gene Panel

It extensively covers up to 52 genes and 23 RNA fusion drivers involved in the oncogenesis of solid tumors, providing a thorough understanding of the tumor's genetic profile.

Variant Detection

The assay is capable of identifying a wide range of genetic variations, including single nucleotide variants (SNVs), insertions/deletions (Indels), copy number variations (CNVs), and structural rearrangements. This comprehensive detection offers a complete view of the tumor's genetic landscape.

Analysis Platform

The innovative Oncomine Reporter Platform is used for precise and accurate genetic profiling. This platform integrates genomic data with the latest cancer research, supporting informed clinical decision-making.

Performance

The assay demonstrates exceptional sensitivity, specificity, and accuracy in identifying genetic alterations within solid tumors. This ensures that healthcare providers can access reliable data to guide treatment decisions, ultimately improving patient care.

Get in touch with us

Contact Us